Glycine

Glycine

SCHEMBL2687281

CCCO.NCC(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL2231959 0.87
Glycine SCHEMBL468791 0.87 OR51E2 (0.71)
Glycine SCHEMBL30204 0.87 OR51E2 (0.71)
Glycine SCHEMBL723130 0.87
Glycine SCHEMBL28367785 0.84
Glycine SCHEMBL28072442 0.84
Glycine SCHEMBL2418117 0.84 OR51E2 (0.67)
Glycine SCHEMBL28449741 0.83
Glycine SCHEMBL2361724 0.83
Glycine SCHEMBL6545633 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200197310-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2020-06-25 US disclosed
US-10583086-B2 Technology for preparation of macromolecular microspheres ANSUN BIOPHARMA, INC. (US) 2020-03-10 US disclosed
US-20180071219-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2018-03-15 US disclosed
US-20180028449-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2018-02-01 US disclosed
US-20170079920-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2017-03-23 US disclosed
US-20160235675-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2016-08-18 US disclosed
US-20150359746-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2015-12-17 US disclosed
US-20150290134-A1 TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES NEXBIO, INC. 2015-10-15 US disclosed
CN-104758253-A Technology for preparation of macromolecular microspheres NEXBIO INC 2015-07-08 CN disclosed
US-20150050713-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2015-02-19 US disclosed
CN-103784408-A Technology for the preparation of microparticles ANSUN BIOPHARMA INC 2014-05-14 CN disclosed
US-20140099696-A1 Technology for the Preparation of Microparticles ANSUN BIOPHARMA, INC. (US) 2014-04-10 US disclosed
US-8623419-B2 Technology for preparation of macromolecular microspheres ANSUN BIOPHARMA, INC. (US) 2014-01-07 US disclosed
US-20120141590-A1 Technology for the Preparation of Microparticles MALAKHOV MICHAEL (US) 2012-06-07 US disclosed
US-20120116062-A1 TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES ANSUN BIOPHARMA, INC. 2012-05-10 US disclosed
CN-101848704-A Techniques for preparing microparticles NEXBIO INC 2010-09-29 CN disclosed
US-20100166874-A1 Technology for Preparation of Macromolecular Microspheres NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-07-01 US disclosed
US-20090098207-A1 Technology for the Preparation of Microparticles NEXBIO, INC. (US) 2009-04-16 US disclosed
CN-101404980-A Preparation Technology of Macromolecular Microspheres NEXBIO INC (US) 2009-04-08 CN disclosed
US-20070190163-A1 Technology for preparation of macromolecular microspheres THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTE OF HEALTH 2007-08-16 US disclosed